Are you Dr. Dubey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-9888Fax+1 415-353-7150
Summary
- Dr. Sarita Dubey, MD is an oncologist in San Francisco, California. She is currently licensed to practice medicine in California.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2001 - 2003
Hennepin HealthcareResidency, Internal Medicine, 1998 - 2001
Kilpauk Medical CollegeClass of 1994
Certifications & Licensure
CA State Medical License 2006 - 2025
Clinical Trials
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery Start of enrollment: 2005 Dec 01
- ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 210 citationsRilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label,...Timothy Iveson, Ross C. Donehower, Irina Davidenko, Sergey Tjulandin, Andrzej Deptala
The Lancet. Oncology. 2014-08-01 - 18 citationsA Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-St...Bonnie S. Glisson, Benjamin Besse, Manuel Cobo Dols, Sarita Dubey, Marco Schupp
Clinical Lung Cancer. 2017-11-01 - 71 citationsA randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal c...Allen Lee Cohn, Josep Tabernero, Juan Maurel, Elżbieta Nowara, Javier Sastre
Annals of Oncology. 2013-07-01
